Expression of the IAP protein family acts cooperatively to predict prognosis in human bladder cancer patients

Oncology Letters

Volumn 5, Issue 4, 2013, Pages 1278-1284

  Chen, Xiaochi ^a   Wang, Tiezheng ^a   Yang, Deyong ^a   Wang, Jianbo ^a   Li, Xiancheng ^a   He, Zhongzhou ^a   Chen, Feng ^a   Che, Xiangyu ^a   Song, Xishuang ^a  

^a DALIAN MEDICAL UNIVERSITY   (China)

Author keywords

Bladder cancer; Cooperatively; Inhibitors of apoptosis; Prognosis

Indexed keywords

INHIBITOR OF APOPTOSIS PROTEIN; INHIBITOR OF APOPTOSIS PROTEIN 1; INHIBITOR OF APOPTOSIS PROTEIN 2; LIVIN; SURVIVIN; X LINKED INHIBITOR OF APOPTOSIS;

ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER GRADING; CANCER LOCALIZATION; CANCER PROGNOSIS; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MALE; RECURRENCE FREE SURVIVAL; TUMOR GROWTH; UROTHELIUM; WESTERN BLOTTING;

EID: 84874442886     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2013.1150     Document Type: Article

References (30)

1. Sylvester RJ, van der Meijden AP, Oosterlinck W, et al: Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: A combined analysis of 2596 patients from seven EORTC trials. Eur Urol 49: 466-475, 2006.
2. Vaux DL and Silke J: Mammalian mitochondrial IAP binding proteins. Biochem Biophys Res Commun 304: 499-504, 2003.
3. Wei Y, Fan T and Yu M: Inhibitor of apoptosis proteins and apoptosis. Acta Biochim Biophys Sin (Shanghai) 40: 278-288, 2008.
4. Srinivasula SM and Ashwell JD: IAPs: what's in a name? Mol Cell 30: 123-135, 2008.
5. Dubrez-Daloz L, Dupoux A and Cartier J: IAPs: more than just inhibitors of apoptosis proteins. Cell Cycle 7: 1036-1046, 2008.
6. LaCasse EC, Mahoney DJ, Cheung HH, et al: IAP-targeted therapies for cancer. Oncogene 27: 6252-6275, 2008.
7. Dohi T, Okada K, Xia F, et al: An IAP-IAP complex inhibits apoptosis. J Biol Chem 279: 34087-34090, 2004.
8. Cheung HH, Plenchette S, Kern CJ, et al: The RING domain of cIAP1 mediates the degradation of RING-bearing inhibitor of apoptosis proteins by distinct pathways. Mol Biol Cell 19: 2729-2740, 2008.
9. Conze DB, Albert L, Ferrick DA, et al: Posttranscriptional downregulation of c-IAP2 by the ubiquitin protein ligase c-IAP1 in vivo. Mol Cell Biol 25: 3348-3356, 2005.
10. Vucic D and Fairbrother WJ: The inhibitor of apoptosis proteins as therapeutic targets in cancer. Clin Cancer Res 13: 5995-6000, 2007.
11. Che X, Yang D, Zong H, et al: Nuclear cIAP1 overexpression is a tumor stage-and grade-independent predictor of poor prognosis in human bladder cancer patients. Urol Oncol 30: 450-456, 2012.
12. Gazzaniga P, Gradilone A, Giuliani L, et al: Expression and prognostic significance of LIVIN, SURVIVIN and other apoptosis-related genes in the progression of superficial bladder cancer. Ann Oncol 14: 85-90, 2003.
13. Li M, Song T, Yin ZF, et al: XIAP as a prognostic marker of early recurrence of nonmuscular invasive bladder cancer. Chin Med J 120: 469-473, 2007.
14. Yin W, Chen N, Zhang Y, et al: Survivin nuclear labeling index: a superior biomarker in superficial urothelial carcinoma of human urinary bladder. Mod Pathol 19: 1487-1497, 2006.
15. Mehrotra S, Languino LR, Raskett CM, et al: IAP regulation of metastasis. Cancer Cell 17: 53-64, 2010.
16. Jin HS, Lee DH, Kim DH, et al: cIAP1, cIAP2, and XIAP act cooperatively via nonredundant pathways to regulate genotoxic stress-induced nuclear factor-κB activation. Cancer Res 69: 1782-1791, 2009.
17. Yang D, Song X, Zhang J, et al: Therapeutic potential of siRNA-mediated combined knockdown of the IAP genes (Livin, XIAP, and Survivin) on human bladder cancer T24 cells. Acta Biochim Biophys Sin (Shanghai) 42: 137-144, 2010.
18. Rodríguez-Berriguete G, Fraile B, de Bethencourt FR, et al: Role of IAPs in prostate cancer progression: immunohistochemical study in normal and pathological (benign hyperplastic, prostatic intraepithelial neoplasia and cancer) human prostate. BMC Cancer 10: 18, 2010.
19. Lopes RB, Gangeswaran R, McNeish IA, et al: Expression of the IAP protein family is dysregulated in pancreatic cancer cells and is important for resistance to chemotherapy. Int J Cancer 120: 2344-2352, 2007.
20. Samuel T, Okada K, Hyer M, et al: cIAP1 Localizes to the nuclear compartment and modulates the cell cycle. Cancer Res 65: 210-218, 2005.
21. Stauber RH, Mann W and Knauer SK: Nuclear and cytoplasmic survivin: molecular mechanism, prognostic, and therapeutic potential. Cancer Res 67: 5999-6002, 2007.
22. Amantana A, London CA, Iversen PL and Devi GR: X-linked inhibitor of apoptosis protein inhibition induces apoptosis and enhances chemotherapy sensitivity in human prostate cancer cells. Mol Cancer Ther 3: 699-707, 2004.
23. Gill C, Dowling C, O'Neill AJ and Watson RW: Effects of cIAP-1, cIAP-2 and XIAP triple knockdown on prostate cancer cell susceptibility to apoptosis. cell survival and proliferation. Mol Cancer 8: 39, 2009.
24. Vischioni B, van der Valk P, Span SW, et al: Expression and localization of inhibitor of apoptosis proteins in normal human tissues. Hum Pathol 37: 78-86, 2006.
25. Ma L, Huang Y, Song Z, et al: Livin promotes Smac/DIABLO degradation by ubiquitin-proteasome pathway. Cell Death Differ 13: 2079-2088, 2006.
26. Chen F, Yang D, Wang S, et al: Livin regulates prostate cancer cell invasion by impacting the NF-κB signaling pathway and the expression of FN and CXCR4. IUBMB Life 64: 274-283, 2012.
27. Xi RC, Biao WS and Gang ZZ: Significant elevation of surviving and livin expression in human colorectal cancer: inverse correlation between expression and overall survival. Onkologie 34: 428-432, 2011.
28. Li WQ, Li XL, Wang GP and Fu B: Gene expression of livin and survivin in adult patients with acute lymphoblastic leukemia and its clinical significance. Zhongguo Shi Yan Xue Ye Xue Za Zhi 19: 921-925, 2011 (In Chinese).
29. Peng XH, Karna P, O'Regan RM, et al: Down-regulation of inhibitor of apoptosis proteins by deguelin selectively induces apoptosis in breast cancer cells. Mol Pharmacol 71: 101-111, 2007.
30. Choi S, Lew KL, Xiao H, et al: D, L-Sulforaphane-induced cell death in human prostate cancer cells is regulated by inhibitor of apoptosis family proteins and Apaf-1. Carcinogenesis 28: 151-162, 2007.